Hair Loss Telehealth Comparison (2026): Hims, Keeps, Roman, Happy Head, Strut — Honestly
📌 TL;DR
- The five services all prescribe the same FDA-approved generic drugs — oral finasteride and 5% topical minoxidil — alongside their own branded shampoos and (for some) compounded multi-ingredient topicals. The drug behind your prescription is the same generic regardless of which logo is on the bottle.
- Pricing is broadly comparable for the standard generics ($20–40/month for finasteride, similar for minoxidil), and meaningfully higher for compounded combos ($60–120/month). The real cost question is whether the convenience is worth the markup over a $4 generic from a retail pharmacy with a written prescription.
- Telehealth's genuine wins are convenience, anonymity, and access for people without easy dermatology coverage. The genuine limitation is that an asynchronous online intake form cannot rule out the conditions that look like — but are not — androgenetic alopecia.
- Compounded 'custom' topicals (Happy Head, Strut, Hims premium tier) combine minoxidil with finasteride, sometimes retinoic acid or biotin. The individual drugs have evidence; the specific compounded combos generally do not have RCT data for that exact formulation. You are paying for convenience, not a proven superior formula.
- Best use case: a man with a clear pattern hairline recession who has read up, knows his Norwood stage, and wants generic finasteride or minoxidil with low friction. Worst use case: anyone with patchy loss, scaling, sudden shedding, or any sign that the loss is not classic androgenetic alopecia — that needs an in-person dermatologist with trichoscopy, not a 5-minute intake form.
Hair Loss Telehealth Comparison (2026): Hims, Keeps, Roman, Happy Head, Strut — Honestly
Last updated: June 2026 | Written by RK
Five companies dominate the US hair-loss telehealth space in 2026: Hims, Keeps, Roman (Ro), Happy Head, and Strut Health. They all do something genuinely useful — they make FDA-approved hair-loss medications easy to get without an in-person clinic visit — and they all do something genuinely worth understanding before signing up: they sell a subscription service whose business model depends on you not cancelling.
This review walks honestly through what each prescribes, what it costs, where telehealth genuinely helps, and where seeing an actual dermatologist still matters more than a one-click intake. It is editorial — no affiliate links, no commission on the services discussed, no pressure to switch you to a particular brand. For the broader treatment picture see best hair loss treatments; for stage-based context see the Norwood scale guide.
What each service actually prescribes
All five services prescribe from a small core menu — the same FDA-approved drugs every dermatologist would consider. The branding is heavier than the pharmacology.
Pricing reflects mid-2026 subscription rates and shifts with promotions and shipment cadence; check current rates before committing.
The core observation: the FDA-approved generics are the same drug everywhere. Hims’s finasteride is the same generic finasteride 1 mg that Keeps and Roman dispense, that a CVS would dispense with a written prescription, that the Kaufman 1998 phase-III trial enrolled men onto [1]. The 5% topical minoxidil is the same generic across all five services, with the same Olsen 2002 efficacy data behind it [2]. What you’re choosing between is workflow, packaging and price — not pharmacology.
What telehealth genuinely does well
Three real benefits, listed honestly because they matter:
- Convenience and access. For a man living in a state with limited dermatology coverage, or whose schedule cannot accommodate a 2-week wait for a 15-minute clinic visit, telehealth is genuinely the difference between treating and not treating. The bar to start finasteride goes from “find a derm + book + travel + pay copay + fill prescription” to “fill a form + review + ship.” That matters.
- Anonymity and de-stigmatisation. Pattern hair loss in your 20s is medically routine and psychologically loaded. The friction of saying it out loud in person stops a non-trivial number of men from treating early — when treatment yields the most. Telehealth removes that friction.
- Cost transparency vs typical US healthcare. The subscription pricing is, at minimum, predictable. Compare to a derm visit copay + lab + prescription where the patient sometimes does not know the total cost until the bill arrives.
These are real and they are why the category exists.
What telehealth genuinely misses
Three real limitations, listed equally honestly:
- The diagnostic step. An asynchronous intake form cannot do trichoscopy, cannot rule out frontal fibrosing alopecia in a postmenopausal woman (see the menopausal hair loss guide), cannot distinguish telogen effluvium sitting on top of pattern loss, and cannot tell whether a Norwood “III” estimate is actually a “IV” with diffuse miniaturisation. For classic, well-presenting pattern hair loss it works. For anything atypical it does not.
- Subscription economics. Every service in the table runs on auto-renewing subscriptions. That is not inherently wrong, but it is a business model designed to make stopping harder than starting. Read the cancellation terms before signing up.
- Off-label and complex cases need a human. Oral minoxidil in a woman with cardiac history, dutasteride switch after finasteride failure, topical finasteride for a man with sexual side effects, PCOS hair loss needing anti-androgens — these are real conversations that benefit from a doctor who can see the whole picture, not a 5-minute intake.
The compounded “custom topical” question
Happy Head, Strut, and Hims’s premium tier all sell compounded multi-active topical formulas — typically minoxidil + finasteride, sometimes with retinoic acid or biotin added — marketed as personalised solutions. This deserves a clear-eyed look:
- The individual ingredients have evidence. Topical minoxidil has decades of trial data [2]. Topical finasteride has growing evidence for serum-DHT reduction with lower systemic exposure than oral [3]. Retinoic acid has mechanistic support for follicular environment effects. Biotin has none meaningful for non-deficient adults (see the biotin myth).
- The specific compounded combinations do not generally have published RCTs for that exact formulation. A trial of “Happy Head’s specific 5+0.025+0.01% formula” does not exist. The argument is mechanistic — combine drugs with separate evidence and expect additive effect.
- The “custom for you” framing implies more personalisation than the actual compounding represents. Most patients on the same service receive substantially similar formulas; the customisation is real but bounded.
The honest reading: compounded topicals are a reasonable convenience format if you specifically want topical finasteride alongside minoxidil (which is increasingly mainstream — see the topical finasteride guide). They are not a clinically-proven superior formula relative to using the components separately. Pay for the convenience honestly; do not pay for an evidence claim that is not there.
Telehealth vs in-person dermatologist
- • The drug evidence does not depend on who prescribes it
- • Pricing is reasonable for the generics
- • Convenience genuinely matters for adherence over years
- • Trichoscopy is genuinely useful here
- • Differential includes FFA, telogen effluvium, alopecia areata
- • Treatment menu (spironolactone, hormone considerations) needs real medical judgment
- • Patches → consider alopecia areata
- • Scaling or scarring → inflammatory or scarring alopecia (urgent)
- • Sudden shedding → telogen effluvium, work-up needed
- • Diagnosis already made; treatment plan known
- • Subscription convenience pays off here
- • Compare prices — they vary more than the drug does
The two channels — telehealth and in-person derm — are not in conflict. They fit different points in the patient journey, and many people use both.
How to evaluate a service before signing up
A short checklist worth running through whichever service you are considering:
- Read the actual subscription terms — auto-renewal cadence, cancellation method, return policy. The marketing page is not the terms.
- Compare price per actual dose of the generic drug, not the headline subscription price. A “$15/month” minoxidil bottle that contains a 4-week supply at twice-daily use is different from a 6-week supply.
- Check what the intake actually asks. Good intake forms ask about your family hair-loss history, your stage, your other medications, your concerns about sexual side effects. Weak intake forms do not.
- Look at the doctor review process. Async review by a licensed physician is the minimum standard. Some services emphasise dermatologist review specifically (Happy Head, Strut); others use general physicians or NPs.
- Confirm the medication source. Generic finasteride and minoxidil from FDA-approved manufacturers are the standard. Compounded products come from a state-licensed compounding pharmacy and are a different regulatory category.
- Plan the cancellation up front. The single most useful question is “how do I cancel?” — answer it before you start.
The honest verdict
The five services are more similar than the marketing implies. The drugs are the same generics. The pricing differences for the standard menu are modest. The real differentiator is the compounded multi-active topical category — where Happy Head and Strut have built deeper offerings than the bigger players, and where the additional cost is meaningful — and the service feel: focused-on-hair (Keeps), broad-men’s-health (Hims, Roman), derm-led-and-clinical (Happy Head, Strut).
For a textbook pattern-hair-loss case in someone who knows their Norwood stage, any of the five will dispense the right drugs at reasonable cost. For anything atypical, none of them are the right answer — see a dermatologist in person.
Telehealth is best understood as a prescription-refill channel that happens to be very efficient for the simple cases. It is not best understood as a substitute for diagnosis. Use it where it fits; do not stretch it where it does not.
What to read next
- Best Hair Loss Treatments (2026) — the evidence-graded overview of the drugs telehealth services dispense.
- Norwood Scale Explained (2026) — know your stage before any intake form asks.
- Topical Finasteride for Hair Loss (2026) — the category most-served by compounded telehealth.
- Finasteride Side Effects: Real Data (2026) — the conversation telehealth intake forms often shortchange.
- Nutrafol Honest Review (2026) — the most-marketed supplement in the same DTC ecosystem.
References
Disclaimer: This article is editorial, not paid promotion. The author has no financial relationship with Hims, Keeps, Roman/Ro, Happy Head, or Strut Health and receives no commission on the services discussed. Subscription pricing reflects publicly listed rates as of mid-2026 and shifts with promotions and policy changes; verify before signing up. Treatment decisions for hair loss should be made with consideration of individual context — telehealth is one channel, an in-person dermatologist is another, and the right answer depends on your specific presentation.
